ZKS Suedbrandenburg GmbH
About ZKS Suedbrandenburg GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Boehringer Ingelheim
2
Calliditas Therapeutics AB
1
Clinical Trials at ZKS Suedbrandenburg GmbH
During the past decade, ZKS Suedbrandenburg GmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
2011-05-01
2012-05-01
Completed
990
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
2013-10-01
2015-03-01
Completed
200
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
2015-12-22
2017-09-20
Completed
977
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ZKS Suedbrandenburg GmbH"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at ZKS Suedbrandenburg GmbH
According to Clinical.Site data, the most researched conditions in "ZKS Suedbrandenburg GmbH" are
"Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Type 2 Diabetes Mellitus With Diabetic Nephropathy" (1 trials) and "Urinary Bladder, Overactive" (1 trials). Many other conditions were trialed in "ZKS Suedbrandenburg GmbH" in a lesser frequency.
Clinical Trials Intervention Types at ZKS Suedbrandenburg GmbH
Most popular intervention types in "ZKS Suedbrandenburg GmbH" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials), "Fesoterodine 8 mg" (1 trials) and "GKT137831" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ZKS Suedbrandenburg GmbH
The vast majority of trials in "ZKS Suedbrandenburg GmbH" are
6 trials for "All" genders.
Clinical Trials Status at ZKS Suedbrandenburg GmbH
Currently, there are NaN active trials in "ZKS Suedbrandenburg GmbH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in ZKS Suedbrandenburg GmbH,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in ZKS Suedbrandenburg GmbH, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".